Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Chemotherapy With Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases- Randomized Phase III Study

NCT00156975 is registered in ClinicalTrials.gov with Arbeitsgruppe Lebermetastasen und Tumoren as lead sponsor.

NCT NCT00156975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00156975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Chemotherapy With Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases- Randomized Phase III Study
Lead sponsor
Arbeitsgruppe Lebermetastasen und Tumoren
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2004
Completion date
Not reported
Enrollment
384
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasms, liver metastases